NF1, Legius Syndrome, and RASopathies
TESTING OPTIONS:
Blood-based
- Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 only (NF1-NG)
- Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 and SPRED1 (NFSP-NG)
- Non-NF1 Rasopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of LZTR1 and SPRED1 (NNP-NG)
- Expanded NF1-Rasopathy panel by Next-Gen Sequencing and Deletion/Duplication of LZTR1, NF1, and SPRED1 (RAS-NG)
- Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)
- Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 only (SPD1-NG)
- Next-Gen Sequencing of HRAS Only for Costello Syndrome (CST-NG)
- Next-Gen Sequencing of GNAS Only for McCune-Albright Syndrome (GNAS-NG)
- RNA-based NF1 Testing on Blood (NF1-R)
- RNA-based NF1 and gDNA-based SPRED1 Testing on Blood (NFSP-R)
Biopsy-based
Contact with the MGL is required prior to taking biopsy/biopsies from your patient so that individualized advice and ship out of appropriate collection/transport media can be provided in advance of the procedure.
Fresh/Frozen Tumor-based
For more information, test requisition forms, or sample collection and mailing kits, please call: 205-934-5562
← Return to Testing Services